Equillium Inc (EQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EQ | AMGN | BMY | GILD | ILMN |
| Company | Equillium Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.8700 | 337.03 | 49.89 | 84.39 | 134.92 |
| High | 0.8846 | 338.70 | 50.04 | 84.65 | 136.19 |
| Low | 0.8500 | 334.61 | 49.11 | 83.57 | 133.88 |
| Last | 0.8601 | 337.16 | 49.62 | 84.15 | 134.44 |
| Change | +0.0101 | +4.24 | -0.12 | +0.26 | +3.47 |
| % Change | +1.19% | +1.27% | -0.24% | +0.31% | +2.65% |
| Volume | 57,591 | 770,566 | 3,703,643 | 4,656,999 | 632,408 |
| 20-Day Average Volume | 187,554 | 1,717,040 | 8,349,274 | 6,476,527 | 1,323,943 |
| Previous Close | 0.8500 | 332.92 | 49.74 | 83.89 | 130.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9509 | 329.65 | 49.11 | 80.09 | 129.23 |
| 20-Day Raw Stochastic | 6.27% | 90.83% | 67.92% | 93.92% | 92.99% |
| 20-Day Relative Strength | 47.37% | 58.56% | 56.45% | 72.65% | 61.10% |
| Weighted Alpha | -47.78 | +27.73 | -9.97 | +19.03 | +9.18 |
| Today's Opinion | 56% Sell | 96% Buy | 72% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 72% Sell | 88% Buy | 72% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 56% Sell | 88% Buy | 40% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.14% since 09/12/24 | +2.15% since 09/12/24 | +2.63% since 09/12/24 | +1.38% since 09/12/24 | +6.96% since 09/12/24 |
| Low | 0.8300 on 09/16/24 | 327.15 on 09/13/24 | 48.20 on 09/13/24 | 81.57 on 09/13/24 | 126.31 on 09/13/24 |
| High | 0.9398 on 09/13/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 136.13 on 09/19/24 |
| 1-Month | |||||
| %Chg | +10.26% since 08/19/24 | +2.80% since 08/19/24 | +0.43% since 08/19/24 | +13.24% since 08/19/24 | -0.63% since 08/19/24 |
| Low | 0.7801 on 08/20/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.34 on 08/20/24 | 120.51 on 09/12/24 |
| High | 1.3100 on 08/29/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | +24.65% since 06/18/24 | +10.19% since 06/18/24 | +21.32% since 06/18/24 | +33.51% since 06/18/24 | +24.92% since 06/18/24 |
| Low | 0.6006 on 08/06/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 103.52 on 06/28/24 |
| High | 1.3100 on 08/29/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | -68.03% since 03/19/24 | +24.08% since 03/19/24 | -4.42% since 03/19/24 | +14.85% since 03/19/24 | +1.41% since 03/19/24 |
| Low | 0.6006 on 08/06/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 100.08 on 05/30/24 |
| High | 2.9850 on 03/22/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 29,967 | 178,589,936 | 100,827,960 | 104,514,608 | 20,863,522 |
| Shares Outstanding, K | 35,255 | 536,435 | 2,027,100 | 1,245,853 | 159,300 |
| Annual Sales | 36,080,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -13,340,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 13,850,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 1,112,000,000 |
| Last Quarter Net Income | 470,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,988,000,000 |
| 60-Month Beta | 1.84 | 0.61 | 0.46 | 0.18 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 08/08/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 08/14/24 | 10/29/24 | 10/31/24 | 11/05/24 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 36.12 | 17.67 | 141.53 |